Omnicell Q3 2026: Service Margins Power a Sixth Straight Earnings Beat

As seen on the 24/7 Wall St. homepage on October 29, 2026.

OMCL Omnicell
Q3 2026
EPS
$0.58
est $0.42 +38.9%
Revenue
$308M
est $304M +1.1%

Margin is doing the work: service gross margin widened to 46.7% from 40.4% a year ago, carrying a sixth straight quarter of profit beating expectations even as revenue slipped 0.9%. Omnicell raised full-year EPS guidance to $2.48 to $2.56, though fourth-quarter revenue guidance of $295 million to $301 million points to a sequential step-down.

Continue ReadingShow less

Omnicell posted adjusted earnings of $0.58 per share for the third quarter of 2026, topping expectations for the sixth consecutive quarter. That streak matters for judging whether margin gains are durable.

Service gross margin widened to 46.7% from 40.4% a year ago, the engine behind the beat. Revenue also came in above estimates even as total sales slipped year over year.

Omnicell raised full-year non-GAAP EPS guidance to $2.48 to $2.56 and lifted its EBITDA outlook, a sign management sees the margin story holding beyond one quarter.

Sponsored

The catch is the fourth quarter: EPS guidance of $0.41 to $0.49 sits below the $0.58 just delivered. Keep an eye on whether service margin expansion holds as the top line pulls back.

CEO Randall Lipps pointed to customer interest in Titan XT combined with OmniSphere, the cloud-native platform for autonomous medication management, as a source of pipeline momentum.

Mentioned: OMCL